Albireo Reports Q2 Financial Results and Business Update
– BylvayTM (odevixibat) approved in U.S. & EU as only once-daily drug indicated for patients with PFIC – – Commercialization...
Day: August 5, 2021
Galecto Reports Second Quarter Operating and Financial Results
BOSTON, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
Greenrose Acquisition Corp. Enters Agreements for Up to $103 Million in Additional Capital
AMITYVILLE, N.Y., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW) (Greenrose), a special purpose acquisition...
Fluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision Medicine
Objective of Agreement is Comprehensive Portfolio for Biomarker Discovery and Drug DevelopmentSOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE)...
Homology Medicines Appoints Gene Therapy Pioneer Beverly Davidson, Ph.D., as Chair of Scientific Advisory Board
- ASGCT President and Entrepreneur Takes Leadership Role on SAB as Company Expects to Have Three Clinical Programs in 2021...
TFF Pharmaceuticals to Present at the Investor Summit Virtual Conference on August 18, 2021
AUSTIN, Texas, Aug. 05, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and...
Evoke Pharma to Report Second Quarter 2021 Financial Results on August 12, 2021
SOLANA BEACH, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on...
Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference
BOULDER, Colo., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company advancing new treatments for...
TFF Pharmaceuticals to Present at the SNN Virtual Investor Conference on August 19, 2021
AUSTIN, Texas, Aug. 05, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and...
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2021 Financial Results
WARREN, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
Vaxcyte Announces Expanded CARB-X Award to Advance Development of VAX-A1, a Vaccine to Prevent Group A Streptococcus Infections
-- Award Commits an Additional $3.2 Million in Funding; Total Potential Funding of $29.7 Million Based on Future Milestones --...
Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test
Digital Health Advertising and Social Media Campaigns launching alongside new siteCurrently in discussion with major retailers to increase distribution of...
INmune Bio, Inc. to Present at the BTIG Virtual Biotechnology Conference
LA JOLLA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused...
Novan to Report Second Quarter 2021 Financial Results on August 12, 2021
Company to host conference call and webcast on Thursday, August 12, 2021, at 8:30 a.m. ETDURHAM, N.C., Aug. 05, 2021...
Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2 for the Treatment of Melanoma and Non-Small Cell Lung Cancer (NSCLC)
Novel iNKT agonist leads to a broad reprogramming of the innate and adaptive immune system to target cancerPORT-2 has the...
Monopar Reaches Target Number of Clinical Sites in Phase 2b Portion of 2b/3 Validive® VOICE Trial
WILMETTE, Ill., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on...
Immutep Reports Dosing of First Patient for Triple Combination (efti + anti-PD-1 + chemo) in INSIGHT-003
Sydney, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), a biotechnology company...
HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe
HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology Intended to serve as one of...
Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and...
Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2021 Financial Results on August 12, 2021
Company to host conference call and webcast at 4:30 p.m. ET on Thursday, August 12.NEWTOWN, Pa., Aug. 05, 2021 (GLOBE...